STOCK TITAN

[Form 4] TERADYNE, INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Teradyne director and President & CEO Gregory Stephen Smith reported a sale of 554 shares of Teradyne common stock on 09/12/2025 at a price of $115 per share. The Form 4 shows 96,438.995 shares remained beneficially owned by Mr. Smith after the reported sale. The filing states the shares were sold under a sales plan adopted February 4, 2025 that was intended to comply with Rule 10b5-1, indicating the transaction followed a prearranged insider trading plan. The Form 4 was signed by an attorney-in-fact on 09/16/2025.

Il direttore di Teradyne, nonché Presidente e Amministratore Delegato, Gregory Stephen Smith, ha comunicato la vendita di 554 azioni ordinarie Teradyne in data 12/09/2025 a un prezzo di 115 dollari per azione. Il Form 4 mostra che, dopo la vendita comunicata, restavano in titolarità beneficiaria 96.438,995 azioni.

Il documento indica che le azioni sono state vendute ai sensi di un piano di vendita adottato il 4 febbraio 2025, finalizzato a conformarsi alla Regola 10b5-1, il che indica che la transazione è avvenuta secondo un piano di trading interno predefinito. Il Form 4 è stato firmato da un procuratore in qualità di agente il 16/09/2025.

El director de Teradyne y Presidente y CEO, Gregory Stephen Smith, informó la venta de 554 acciones comunes de Teradyne el 12/09/2025 a un precio de 115 dólares por acción. El Form 4 indica que, tras la venta reportada, Smith mantiene la titularidad beneficiaria de 96.438,995 acciones.

El documento señala que las acciones se vendieron bajo un plan de ventas adoptado el 4 de febrero de 2025 para cumplir con la Regla 10b5-1, lo que indica que la transacción siguió un plan de trading interno preestablecido. El Form 4 fue firmado por un apoderado el 16/09/2025.

Teradyne 이사 및 회장 겸 CEO인 Gregory Stephen Smith가 2025년 9월 12일 주당 115달러에 Teradyne 보통주 554주를 매도했다고 보고했습니다. 양식 4에 따르면 보고된 매도 이후 Smith 씨의 수익지분은 96,438.995주로 남아 있습니다.

해당 서류는 주식이 2025년 2월 4일에 채택된 매도 계획에 따라 매도되었으며, 이 계획은 Rule 10b5-1을 준수하기 위한 것이며 선 매매 내부 거래 계획에 따라 거래가 이루어졌음을 시사합니다. 양식 4는 2025년 9월 16일에 대리인에 의해 서명되었습니다.

Le directeur de Teradyne et Président-Directeur Général, Gregory Stephen Smith, a annoncé la vente de 554 actions ordinaires Teradyne le 12/09/2025 au prix de 115 dollars par action. Le formulaire 4 indique qu’après cette vente, M. Smith détenait encore 96 438,995 actions en propriété bénéficiaire.

Le document précise que les actions ont été vendues dans le cadre d’un plan de vente adopté le 4 février 2025 et destiné à respecter la règle 10b5-1, indiquant que la transaction a suivi un plan de trading interne préétabli. Le formulaire 4 a été signé par un mandataire le 16/09/2025.

Der Teradyne-Direktor und Präsident & CEO Gregory Stephen Smith meldete den Verkauf von 554 Teradyne-Stammaktien am 12.09.2025 zu einem Preis von 115 USD pro Aktie. Das Formular 4 zeigt, dass nach dem gemeldeten Verkauf weiterhin 96.438,995 Aktien im wirtschaftlichen Eigentum von Herrn Smith verblieben.

Im Einreichungstext wird angegeben, dass die Aktien gemäß einem am 4. Februar 2025 verabschiedeten Verkaufsplan verkauft wurden, der darauf abzielt, Rule 10b5-1 zu erfüllen, was darauf hindeutet, dass die Transaktion einem vorab festgelegten Insider-Handelsplan folgte. Das Formular 4 wurde am 16.09.2025 von einem Bevollmächtigten unterzeichnet.

أعلن مدير Терاديين ورئيسها التنفيذي Gregory Stephen Smith عن بيع 554 سهماً من أسهم Teradyne العادية في 12/09/2025 بسعر 115 دولاراً للسهم الواحد. يظهر النموذج 4 أن الأسهم بقيت مملوكةً للفرد بشكل مستفيد بقيمة 96,438.995 سهماً بعد البيع المبلغ عنه.

ينص الملف أن الأسهم بيعت بموجب خطة بيع اعتمدت في 4 فبراير 2025 وتهدف إلى الامتثال للقاعدة 10b5-1، مما يشير إلى أن المعاملة تمت وفقاً لخطة تداول داخلية مُحددة مسبقاً. كما وقع النموذج 4 بواسطة وكيل قانوني في 16/09/2025.

Teradyne 的董事兼总裁兼首席执行官 Gregory Stephen Smith 于 2025 年 9 月 12 日以每股 115 美元价格出售了 554 股 Teradyne 普通股。 Form 4 显示在该次出售后,Smith 仍以受益所有人身份持有 96,438.995 股。

文件称这些股票是在 2025 年 2 月 4 日通过一个销售计划出售的,旨在符合 10b5-1 条款,表明该交易遵循了事先设定的内部交易计划。Form 4 已于 2025 年 9 月 16 日由一名代理人签署。

Positive
  • Transaction disclosed promptly on Form 4 with specific date and price details
  • Sale executed under a Rule 10b5-1 plan adopted February 4, 2025, indicating prearranged trades
  • Clear post-transaction ownership reported as 96,438.995 shares
Negative
  • Insider sale reported — 554 shares disposed, which may draw investor attention despite being modest

Insights

TL;DR Routine insider sale under a 10b5-1 plan by the CEO and director; disclosure aligns with standard governance practices.

The Form 4 documents a small, scheduled disposition of 554 shares at $115 each by Gregory Stephen Smith, who holds the roles of President & CEO and director. The explicit disclosure that the sale was executed pursuant to a 10b5-1 plan adopted on February 4, 2025 signals adherence to an established trading framework designed to avoid opportunistic insider trading. The remaining beneficial ownership is reported precisely as 96,438.995 shares, which provides clear post-transaction ownership visibility. From a governance perspective, this is routine and compliant, with no indications in the filing of ad hoc or opportunistic timing.

TL;DR A disclosed, modest insider sale that is unlikely to be material to Teradyne’s capitalization or signal company-specific issues.

The transaction size — 554 shares at $115 — represents a de minimis disposition relative to the reported post-sale holding of 96,438.995 shares. The use of a Rule 10b5-1 sales plan reduces interpretive ambiguity for investors about the motivation and timing of the sale. The filing contains the transaction date and price, the plan adoption date, and the signature date via attorney-in-fact, which together meet standard Form 4 disclosure norms. No derivative transactions or additional material events are disclosed in this filing.

Il direttore di Teradyne, nonché Presidente e Amministratore Delegato, Gregory Stephen Smith, ha comunicato la vendita di 554 azioni ordinarie Teradyne in data 12/09/2025 a un prezzo di 115 dollari per azione. Il Form 4 mostra che, dopo la vendita comunicata, restavano in titolarità beneficiaria 96.438,995 azioni.

Il documento indica che le azioni sono state vendute ai sensi di un piano di vendita adottato il 4 febbraio 2025, finalizzato a conformarsi alla Regola 10b5-1, il che indica che la transazione è avvenuta secondo un piano di trading interno predefinito. Il Form 4 è stato firmato da un procuratore in qualità di agente il 16/09/2025.

El director de Teradyne y Presidente y CEO, Gregory Stephen Smith, informó la venta de 554 acciones comunes de Teradyne el 12/09/2025 a un precio de 115 dólares por acción. El Form 4 indica que, tras la venta reportada, Smith mantiene la titularidad beneficiaria de 96.438,995 acciones.

El documento señala que las acciones se vendieron bajo un plan de ventas adoptado el 4 de febrero de 2025 para cumplir con la Regla 10b5-1, lo que indica que la transacción siguió un plan de trading interno preestablecido. El Form 4 fue firmado por un apoderado el 16/09/2025.

Teradyne 이사 및 회장 겸 CEO인 Gregory Stephen Smith가 2025년 9월 12일 주당 115달러에 Teradyne 보통주 554주를 매도했다고 보고했습니다. 양식 4에 따르면 보고된 매도 이후 Smith 씨의 수익지분은 96,438.995주로 남아 있습니다.

해당 서류는 주식이 2025년 2월 4일에 채택된 매도 계획에 따라 매도되었으며, 이 계획은 Rule 10b5-1을 준수하기 위한 것이며 선 매매 내부 거래 계획에 따라 거래가 이루어졌음을 시사합니다. 양식 4는 2025년 9월 16일에 대리인에 의해 서명되었습니다.

Le directeur de Teradyne et Président-Directeur Général, Gregory Stephen Smith, a annoncé la vente de 554 actions ordinaires Teradyne le 12/09/2025 au prix de 115 dollars par action. Le formulaire 4 indique qu’après cette vente, M. Smith détenait encore 96 438,995 actions en propriété bénéficiaire.

Le document précise que les actions ont été vendues dans le cadre d’un plan de vente adopté le 4 février 2025 et destiné à respecter la règle 10b5-1, indiquant que la transaction a suivi un plan de trading interne préétabli. Le formulaire 4 a été signé par un mandataire le 16/09/2025.

Der Teradyne-Direktor und Präsident & CEO Gregory Stephen Smith meldete den Verkauf von 554 Teradyne-Stammaktien am 12.09.2025 zu einem Preis von 115 USD pro Aktie. Das Formular 4 zeigt, dass nach dem gemeldeten Verkauf weiterhin 96.438,995 Aktien im wirtschaftlichen Eigentum von Herrn Smith verblieben.

Im Einreichungstext wird angegeben, dass die Aktien gemäß einem am 4. Februar 2025 verabschiedeten Verkaufsplan verkauft wurden, der darauf abzielt, Rule 10b5-1 zu erfüllen, was darauf hindeutet, dass die Transaktion einem vorab festgelegten Insider-Handelsplan folgte. Das Formular 4 wurde am 16.09.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Smith Gregory Stephen

(Last) (First) (Middle)
TERADYNE, INC.
600 RIVERPARK DRIVE

(Street)
NORTH READING MA 01864

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TERADYNE, INC [ TER ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/12/2025 S(1) 554 D $115 96,438.995 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on February 4, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
/s/ Ryan E. Driscoll, Attorney-in-Fact 09/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Teradyne (TER) shares did Gregory Stephen Smith sell on 09/12/2025?

554 shares were sold on 09/12/2025 according to the Form 4.

At what price were the TER shares sold by the reporting person?

$115 per share is the reported sale price on the Form 4.

How many TER shares does Gregory Stephen Smith beneficially own after the reported sale?

96,438.995 shares are reported as beneficially owned following the transaction.

Was the sale part of a 10b5-1 plan?

Yes. The Form 4 states the shares were sold pursuant to a sales plan adopted February 4, 2025 intended to comply with Rule 10b5-1.

Who signed the Form 4 and when was it signed?

Signed by an attorney-in-fact, Ryan E. Driscoll, on 09/16/2025 as shown on the filing.
Teradyne

NASDAQ:TER

TER Rankings

TER Latest News

TER Latest SEC Filings

TER Stock Data

21.19B
158.62M
0.27%
104.15%
4.46%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
NORTH READING